Table 3.
Study | Number of radical cystectomies | Type of urinary diversion (n) | Followup (months) | Oncologic outcome (n) | Graft function (n) |
---|---|---|---|---|---|
Present | 3 | Neobladder (1) Allograft nephrostomy (1) Cutaneous ureterostomies (1) |
24–98 | NED (3) | Stable (3) |
Kamal et al. [3] | 5 | Neobladder (5) | 3–24 | NED (3) Mets (2) |
Stable (5) |
Lang et al. [25] | 4 | Neobladder (4) | 11–118 | NED (3) Local recurrence (1) |
Stable (3) Chronic allograft nephropathy (1) |
Master et al. [7] | 3 | Neobladder (2) IC (1) |
10–105 | NED (1) Ureteric recurrence (1) Paravaginal recurrence (1) |
Stable (3) |
Kao et al. [26] | 4 | IC (4) | 4–39 | NED (3) Mets (1) |
Unknown |
Palou et al. [27] | 1 | IC (1) | 10 | NED (1) | Stable (1) |
Wang et al. [28] | 0 | ||||
Giessing et al. [29] | 1 | Neobladder (1) | 20 | NED (1) | Stable (1) |
Perabo and Schultze-Seemann [30] | 1 | Neobladder (1) | 8 | NED (1) | Stable (1) |
Colombo et al. [31] | 1 | Neobladder (1) | 8 | NED (1) | Stable (1) |
Schmidt et al. [32] | 1 | Unknown | Unknown | Unknown | Unknown |
Lam et al. [33] | 1 | IC (1) | Unknown | Unknown | Unknown |
Lemmers and Barry [34] | 2 | IC (2) | 6–24 | NED (2) | Stable (2) |
Tuttle et al. [35] | 1 | IC (1) | 14 | NED (1) | Stable (2) |
NED, no evidence of disease; IC, ileal conduit; Mets, metastases.